Literature DB >> 18777199

Differential expression of potassium ion channels in human renal cell carcinoma.

Surbhi Wadhwa1, Pankaj Wadhwa, Amit K Dinda, Narmada P Gupta.   

Abstract

PURPOSE: Ether-a-go-go (EAG) or EAG-related (ERG) voltage-gated potassium ion channels are involved in tumor generation and progression. Their over- and/or misexpression has been demonstrated in various tumors, and inhibition of these channels has suppressed proliferation of various cancer cells. We investigate and compare the pattern of expression of EAG and human ERG (HERG) channels in renal cell carcinoma and "normal" renal tissue.
METHOD: Tissue samples, obtained at the time of radical nephrectomy from the tumor-bearing areas, and uninvolved renal tissue were preserved in 4% paraformaldehyde and cryosectioned at 20 mum. Immunohistochemical and Western blot analysis was performed on the tumor and uninvolved kidney parenchyma by incubating with polyclonal anti-HERG 1b (Alomone Lab, Israel), anti-EAG1, and anti-EAG2. Pattern of expression of EAG/HERG channels in normal renal tissue and carcinoma were noted and compared.
RESULTS: The study was performed on 16 radical and four partial nephrectomy specimens (n = 20). All tumors in the cohort were clear cell renal carcinoma. Normal renal tissue was found to exhibit heterogeneous cytoplasmic positivity for EAG1 and focal HERG immunoreactivity (IR) in the proximal (PCT) and distal convoluted tubules (DCT). EAG2 IR was absent in the normal renal tissue. Clear cell RCC demonstrated a loss of HERG expression while diffuse overexpression of EAG1 and EAG2 was noted. Western blot analysis corroborated the immunohistochemical observations.
CONCLUSIONS: In our study both EAG1 and EAG2 potassium channels were overexpressed in clear cell renal cancer. In contrast to other adenocarcinomas, there is loss of HERG expression in clear cell RCC, which may possibly explain its chemoresistance. These ion channels may provide a potential for targeted therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777199     DOI: 10.1007/s11255-008-9459-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

Review 1.  Function and spatial distribution of ion channels and transporters in cell migration.

Authors:  A Schwab
Journal:  Am J Physiol Renal Physiol       Date:  2001-05

Review 2.  The voltage-gated potassium channels and their relatives.

Authors:  Gary Yellen
Journal:  Nature       Date:  2002-09-05       Impact factor: 49.962

3.  Oncogenic potential of EAG K(+) channels.

Authors:  L A Pardo; D del Camino; A Sánchez; F Alves; A Brüggemann; S Beckh; W Stühmer
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

4.  Regulation of an ERG K+ current by Src tyrosine kinase.

Authors:  Francisco S Cayabyab; Lyanne C Schlichter
Journal:  J Biol Chem       Date:  2002-02-07       Impact factor: 5.157

5.  Effects of imipramine on ion channels and proliferation of IGR1 melanoma cells.

Authors:  O Gavrilova-Ruch; K Schönherr; G Gessner; R Schönherr; T Klapperstück; W Wohlrab; S H Heinemann
Journal:  J Membr Biol       Date:  2002-07-15       Impact factor: 1.843

6.  HERG K+ channel, a regulator of tumor cell apoptosis and proliferation.

Authors:  Huizhen Wang; Yiqiang Zhang; Liwen Cao; Hong Han; Jingxiong Wang; Baofeng Yang; Stanley Nattel; Zhiguo Wang
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

7.  HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors.

Authors:  S Pillozzi; M F Brizzi; M Balzi; O Crociani; A Cherubini; L Guasti; B Bartolozzi; A Becchetti; E Wanke; P A Bernabei; M Olivotto; L Pegoraro; A Arcangeli
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

8.  Molecular identification and characterisation of the human eag2 potassium channel.

Authors:  M Ju; D Wray
Journal:  FEBS Lett       Date:  2002-07-31       Impact factor: 4.124

9.  Expression and activity of potassium ion channels in human prostate cancer.

Authors:  Mansoor Abdul; Naseema Hoosein
Journal:  Cancer Lett       Date:  2002-12-01       Impact factor: 8.679

10.  HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium.

Authors:  A Cherubini; G L Taddei; O Crociani; M Paglierani; A M Buccoliero; L Fontana; I Noci; P Borri; E Borrani; M Giachi; A Becchetti; B Rosati; E Wanke; M Olivotto; A Arcangeli
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  22 in total

Review 1.  The roles of K(+) channels in cancer.

Authors:  Luis A Pardo; Walter Stühmer
Journal:  Nat Rev Cancer       Date:  2013-12-12       Impact factor: 60.716

2.  Ion channels as targets for cancer therapy.

Authors:  Minghua Li; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-06-27

3.  Inducing Polyclonal Eag1-Specific Antibodies by Vaccination with a Linear Epitope Immunogen and Its Relation to Breast Tumorigenesis.

Authors:  Zhandong Li; Ketong Zhu; Xin Gong; Steven Vasilescu; Yu Sun; Kaiqing Hong; Hao Li; Lin Li; Yaming Shan
Journal:  Pathol Oncol Res       Date:  2017-01-09       Impact factor: 3.201

4.  Ceramide modulates HERG potassium channel gating by translocation into lipid rafts.

Authors:  Sindura B Ganapathi; Todd E Fox; Mark Kester; Keith S Elmslie
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-07       Impact factor: 4.249

5.  Increased Expression of Kv10.2 in the Hippocampus Attenuates Valproic Acid-Induced Autism-Like Behaviors in Rats.

Authors:  Jing Wang; Shini Feng; Min Li; Yamei Liu; Jinyu Yan; Yunfei Tang; Dongshu Du; Fuxue Chen
Journal:  Neurochem Res       Date:  2019-11-15       Impact factor: 3.996

6.  AMP-activated protein kinase regulates hERG potassium channel.

Authors:  Ahmad Almilaji; Carlos Munoz; Bernat Elvira; Abul Fajol; Tatsiana Pakladok; Sabina Honisch; Ekaterina Shumilina; Florian Lang; Michael Föller
Journal:  Pflugers Arch       Date:  2013-05-29       Impact factor: 3.657

7.  State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy.

Authors:  Sindura B Ganapathi; Mark Kester; Keith S Elmslie
Journal:  Am J Physiol Cell Physiol       Date:  2009-02-25       Impact factor: 4.249

8.  Englerin a selectively induces necrosis in human renal cancer cells.

Authors:  Florian J Sulzmaier; Zhenwu Li; Mika L Nakashige; David M Fash; William J Chain; Joe W Ramos
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

9.  A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.

Authors:  Guanhua Li; Zuojun Hu; Henghui Yin; Yunjian Zhang; Xueling Huang; Shenming Wang; Wen Li
Journal:  Int J Nanomedicine       Date:  2013-03-27

10.  Behavioural and functional characterization of Kv10.1 (Eag1) knockout mice.

Authors:  Roser Ufartes; Tomasz Schneider; Lena Sünke Mortensen; Camino de Juan Romero; Klaus Hentrich; Hendrik Knoetgen; Vadim Beilinson; Wiebke Moebius; Victor Tarabykin; Frauke Alves; Luis A Pardo; J Nicholas P Rawlins; Walter Stuehmer
Journal:  Hum Mol Genet       Date:  2013-02-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.